Basic principles of biobanking: from biological samples to precision medicine for patients.


Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 13 03 2021
accepted: 30 06 2021
revised: 24 06 2021
pubmed: 14 7 2021
medline: 10 9 2021
entrez: 13 7 2021
Statut: ppublish

Résumé

The term "biobanking" is often misapplied to any collection of human biological materials (biospecimens) regardless of requirements related to ethical and legal issues or the standardization of different processes involved in tissue collection. A proper definition of biobanks is large collections of biospecimens linked to relevant personal and health information (health records, family history, lifestyle, genetic information) that are held predominantly for use in health and medical research. In addition, the International Organization for Standardization, in illustrating the requirements for biobanking (ISO 20387:2018), stresses the concept of biobanks being legal entities driving the process of acquisition and storage together with some or all of the activities related to collection, preparation, preservation, testing, analysing and distributing defined biological material as well as related information and data. In this review article, we aim to discuss the basic principles of biobanking, spanning from definitions to classification systems, standardization processes and documents, sustainability and ethical and legal requirements. We also deal with emerging specimens that are currently being generated and shaping the so-called next-generation biobanking, and we provide pragmatic examples of cancer-associated biobanking by discussing the process behind the construction of a biobank and the infrastructures supporting the implementation of biobanking in scientific research.

Identifiants

pubmed: 34255145
doi: 10.1007/s00428-021-03151-0
pii: 10.1007/s00428-021-03151-0
pmc: PMC8275637
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

233-246

Subventions

Organisme : Ministero della Salute
ID : Ricerca Corrente 2019 ACC
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : 21091
Organisme : Horizon 2020 Framework Programme
ID : SPIDIA4P (contract no. 733112)

Informations de copyright

© 2021. The Author(s).

Références

Value Health. 2020 Aug;23(8):1072-1078
pubmed: 32828220
Biopreserv Biobank. 2012 Oct;10(5):426-32
pubmed: 24845043
Mol Oncol. 2008 Oct;2(3):213-22
pubmed: 19383342
Biopreserv Biobank. 2018 Feb;16(1):3-6
pubmed: 29393664
Nature. 2011 Jul 27;475(7357):454-5
pubmed: 21796190
Biopreserv Biobank. 2016 Dec;14(6):559-562
pubmed: 27936342
Clin Chem. 2019 Jul;65(7):827-832
pubmed: 31088785
Cancers (Basel). 2020 Mar 25;12(4):
pubmed: 32218259
Transfus Clin Biol. 2016 May;23(2):95-7
pubmed: 26711889
Res Involv Engagem. 2015 Jun 25;1:4
pubmed: 29062493
Biopreserv Biobank. 2016 Apr;14(2):99-106
pubmed: 26890981
Clin Cancer Res. 2019 Oct 15;25(20):6243-6259
pubmed: 31375513
Methods Mol Biol. 2019;1897:7-16
pubmed: 30539430
Nat Methods. 2018 Apr 27;15(5):303-304
pubmed: 29702632
Cancer Discov. 2011 Nov;1(6):508-23
pubmed: 22586653
J Mol Med (Berl). 1996 Jun;74(6):297-312
pubmed: 8862511
Biopreserv Biobank. 2020 Jun;18(3):153-154
pubmed: 32297797
PLoS One. 2011;6(6):e21043
pubmed: 21698245
Virchows Arch. 2012 Jul;461(1):79-86
pubmed: 22653529
Nat Commun. 2020 Mar 11;11(1):1310
pubmed: 32161258
Brief Bioinform. 2008 Jan;9(1):14-24
pubmed: 17959611
AIDS. 2013 Jan 28;27(3):303-12
pubmed: 23135167
J Transl Med. 2019 May 22;17(1):172
pubmed: 31118074
N Biotechnol. 2019 Sep 25;52:104-109
pubmed: 31150841
Biopreserv Biobank. 2011 Dec;9(4):327-33
pubmed: 24836628
Biopreserv Biobank. 2018 Dec;16(6):477-482
pubmed: 30335475
Nat Med. 2020 Jun;26(6):809-810
pubmed: 32382152
PLoS One. 2016 Jan 05;11(1):e0145100
pubmed: 26731692
Int J Mol Sci. 2015 Dec 24;17(1):
pubmed: 26712742
Diagnostics (Basel). 2020 Jul 16;10(7):
pubmed: 32708805
Recent Results Cancer Res. 2015;199:1-13
pubmed: 25636424
Curr Opin Biotechnol. 2020 Oct;65:45-51
pubmed: 31896493
Middle East J Dig Dis. 2015 Apr;7(2):61-8
pubmed: 26106464
Eur J Hum Genet. 2015 Jul;23(7):893-900
pubmed: 25407005
BMC Med. 2015 Feb 17;13:33
pubmed: 25855867
Nat Rev Clin Oncol. 2013 Aug;10(8):437-50
pubmed: 23799370
Front Oncol. 2020 Feb 19;10:173
pubmed: 32140450
Cancer Discov. 2015 Aug;5(8):832-41
pubmed: 26243863
Biopreserv Biobank. 2020 Oct;18(5):479-480
pubmed: 32936006
Cell. 2015 May 7;161(4):933-45
pubmed: 25957691
N Engl J Med. 2014 Feb 13;370(7):592-5
pubmed: 24521104
Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):239-246
pubmed: 29959990
Geburtshilfe Frauenheilkd. 2014 Apr;74(4):361-369
pubmed: 25076793
Recent Pat DNA Gene Seq. 2012 Apr;6(1):22-32
pubmed: 22208680
Front Med (Lausanne). 2019 Jun 26;6:141
pubmed: 31294024
Nat Biotechnol. 2011 Sep 08;29(9):795-7
pubmed: 21904320
Clin Biochem. 2014 Mar;47(4-5):300-8
pubmed: 24406300
Biopreserv Biobank. 2013 Oct;11(5):309-15
pubmed: 24835262
Nat Genet. 2011 Jun;43(6):503-4
pubmed: 21614086
PLoS One. 2013 Sep 30;8(9):e75193
pubmed: 24098684
Sci Transl Med. 2014 Nov 5;6(261):261fs45
pubmed: 25378642
Biopreserv Biobank. 2013 Aug;11(4):193
pubmed: 24845583
Cell. 2018 Jan 11;172(1-2):373-386.e10
pubmed: 29224780
Breast Cancer Res. 2013 Oct 01;15(5):R92
pubmed: 24286369
Health Expect. 2020 Aug;23(4):759-788
pubmed: 32378306
Biopreserv Biobank. 2019 Apr;17(2):129-138
pubmed: 30638412
BMC Med Ethics. 2016 Jul 12;17(1):39
pubmed: 27405974
Recent Results Cancer Res. 2015;199:65-70
pubmed: 25636430
J Transl Med. 2018 May 22;16(1):136
pubmed: 29783984
Acad Pathol. 2017 May 08;4:2374289517702924
pubmed: 28725790
Clin Chem. 2018 Aug;64(8):1158-1182
pubmed: 29921725
Nucleic Acids Res. 2019 Jan 8;47(D1):D1073-D1079
pubmed: 30535239
J Cell Physiol. 2012 Jan;227(1):14-9
pubmed: 21412777
Nat Commun. 2017 Feb 10;8:14262
pubmed: 28186126
Nat Med. 2017 Dec;23(12):1424-1435
pubmed: 29131160
Int J Biol Markers. 2016 May 28;31(2):e211-7
pubmed: 26868333
Biopreserv Biobank. 2020 Apr;18(2):144-149
pubmed: 32043910
J Exp Clin Cancer Res. 2017 Sep 13;36(1):128
pubmed: 28903768
J Natl Cancer Inst Monogr. 2011;2011(42):24-31
pubmed: 21672892

Auteurs

Laura Annaratone (L)

Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Department of Medical Sciences, University of Turin, Turin, Italy.

Giuseppe De Palma (G)

Institutional BioBank, Experimental Oncology and Biobank Management Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Giuseppina Bonizzi (G)

Unit of Histopathology and Molecular Diagnostics, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Anna Sapino (A)

Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Department of Medical Sciences, University of Turin, Turin, Italy.

Gerardo Botti (G)

Istituto Nazionale Tumori, Fondazione G. Pascale, IRCCS, Naples, Italy.

Enrico Berrino (E)

Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Department of Medical Sciences, University of Turin, Turin, Italy.

Chiara Mannelli (C)

Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.

Pamela Arcella (P)

Department of Oncology, University of Turin, Turin, Italy.

Simona Di Martino (S)

Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Agostino Steffan (A)

Immunopathology and Cancer Biomarkers, IRCCS CRO Aviano-National Cancer Institute, Aviano, Italy.

Maria Grazia Daidone (MG)

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.

Vincenzo Canzonieri (V)

Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
Pathology Unit, IRCCS CRO Aviano-National Cancer Institute, Aviano, Italy.

Barbara Parodi (B)

IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Angelo Virgilio Paradiso (AV)

Institutional BioBank, Experimental Oncology and Biobank Management Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Massimo Barberis (M)

Unit of Histopathology and Molecular Diagnostics, Division of Pathology and Laboratory Medicine, IEO, European Institute of Oncology, IRCCS, Milan, Italy.

Caterina Marchiò (C)

Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy. caterina.marchio@unito.it.
Department of Medical Sciences, University of Turin, Turin, Italy. caterina.marchio@unito.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH